Nix - Professional Heart Daily
Transcription
Nix - Professional Heart Daily
Diverse mechanisms of Nix-mediated cell death Gerald W Dorn II MD FINANCIAL DISCLOSURE: NHLBI R01s HL059888, HL080008, and HL087871 NHLBI P50s HL077101 and HL077113 UNLABELED/UNAPPROVED USES DISCLOSURE: NHLBI None r h Normal heart Hypertrophic genes TAC/Gαq r h Hypertrophied heart Cardiomyocyte apoptosis Nix r h Cardiomyopathic Dilation What is Nix? • Nix is a transcriptionally regulated member of the pro‐ apoptotic BNip subfamily of Bcl2 proteins. • Unlike members of the pro‐apoptotic BH3‐only subfamily (Bad, Bid, Bim, Puma), the Nix pseudo‐BH3 domain is not required for its death effects. • Whereas BH3‐only factors stimulate mitochondrial apoptosis, Nix stimulates atypical cell death having characteristics of both apoptosis and necrosis. Cell Death and Diff 2009 16:939-46 Aouacheria, A. et al. Mol Biol Evol 2005 22:2395-2416 We know that: • Nix is transcriptionally upregulated in experimental and clinical cardiac hypertrophy (Nat Med 2002; J Biol Chem 2006). • Forced cardiomyocyte expression of Nix is sufficient to cause apoptotic cardiomyopathy, mediated via the mitochondrial pathway (Nat Med 2002; Circ Res 2004). • Cardiomyocyte‐specific Nix gene ablation protects against ventricular remodeling and decreases cardiomyocyte apoptosis after TAC (Circulation 2008). Nix stimulates mitochondrial pathway apoptosis Mitochondrial apoptosis Nix FLAG-Nix Overlay Bax/Bak Apoptosome Cyt c Apaf-1 dATP Casp 9 Mitochondria Casp 3 DNA frag (200 bp) Cell Death Nat Med. 2002 8:725-30 Nix localizes to mitochondria and ER/SR Diwan A et al, J Clin Invest. 119:203-212, 2009 Transfected and endogenous cardiomyocyte Nix localize to mitochondria and ER/SR HEK cells NRCM Mito ER/SR Mouse heart (standard) Mouse heart (sucrose grad) Mito ER/SR Diwan A et al, J Clin Invest. 119:203-212, 2009 Nix overexpression increases SR calcium content Conditional Nix transgenic Diwan A et al, J Clin Invest. 119:203-212, 2009 Nix ablation decreases SR calcium content Conditional Nix transgenic Nix knockout Diwan A et al, J Clin Invest. 119:203-212, 2009 Nix localizes to ER and SR and increases SR Ca++ stores Mitochondrial apoptosis Nix Regulation of SR Ca++ stores Bax/Bak Apoptosome Cyt c Apaf-1 dATP Casp 9 Mitochondria SR Ca++ Casp 3 DNA frag (200 bp) Cell Death Creation of organelle-specific Nix mutants BH3 TM Nix-wt Nix-wt Nix-ActA mitochondria Nix-cb5 ER/SR Nix-trunc No target Mito ER/SR Diwan A et al, J Clin Invest. 119:203-212, 2009 Both mitochondrial- and SR-targeted Nix cause PCD. Adenoviral Nix mutant expression in NRCM SR-targeted, but not mitochondrial-Nix, decreases Δψm No Nix (βgal) Mito and SR Nix Mito Nix-Act A SR Nix-cb5 Diwan A et al, J Clin Invest. 119:203-212, 2009 cytosolic Nix trunc Mitochondrial localization is sufficient for Nix-mediated cell death. Mitochondrial apoptosis Nix-ActA Bax/Bak Apoptosome Cyt c Apaf-1 dATP Casp 9 Mitochondria Casp 3 DNA frag (200 bp) Cell Death Mitochondrial localization is dispensable for Nix-mediated cell death. Nix-cb5 Mitochondrial apoptosis Apoptosome Cyt c Apaf-1 dATP Casp 9 Mitochondria Δψm Casp 3 DNA frag (200 bp) Cell Death SR What are the consequences of organelle‐specific Nix on cardiac function? Genetic mouse experiment Gedankenexperiment Hypothesis Tissue culture experiment Stay tuned to find out………… Nix-cb5 Bax/Bak SR Mitochondria Ca++ TP MP H20 ATP depletion Necrotic Cell Death Mfn1 Mfn2 Opa1 Cell, Volume 135, Issue 7, Pages 1165-1167 Genetic mouse experiment Gedankenexperiment Hypothesis Tissue culture experiment Genetic mouse experiment Gedankenexperiment Hypothesis Tissue culture experiment Genetic fly experiment • • • • • • • • • • • • • Scot Matkovich Abhinav Diwan Yizheng Tu Min Young Kang Derek Van Booven John Engelhard Kyuwan Shim Anna Hindes Will Eschenbacher Mark Snee Yun Chen Lisa Dorn Alina Kutsenko • • • • • Jeanne Nerbonne Steve Warner Greg Longmore Robi Mitra Ken Polonsky • • Cindy Sweet Karen Gill • Jeff Molkentin (ppif ‐/‐) • David Chan (Mfn2 loxP) • Litsa Kranias (Pln ‐/‐)
Similar documents
Institute of Inherited Metabolic Disorders
clinical analysis (division A) – E. Hrubá, Jahnová, E. Košťálová, S. Štastná. biochemical analyses (divisions A and B): J. Ledvinová, H. Poupětová, L. Berná, O. Martinová, E. Pospíšilová, M. Hřebíč...
More information